Staples to acquire PNI Digital Media for CAD1.70 per share in cash
M2 - 26 mins ago
Office products company Staples Inc (Nasdaq:SPLS) and PNI Digital Media (TSX
Staples Enters into Agreement to Acquire PNI Digital Media in Cash Transaction for CDN$1.70 Per Share (Approx CDN$73.9 million)
Marketwire - Mon May 05, 7:32AM CDT
Staples, Inc. (Nasdaq: SPLS) ("Staples"
PNI Digital Media Settles Dispute With Bloom Stationers LLC
Marketwire - Mon May 05, 7:16AM CDT
PNI Digital Media (TSX: PN) (OTCQB: PNDMF) (the "Company"
PNI Digital Media Expands Relationship With Black's to Provide New Online Photo Site
Marketwire - Wed Apr 23, 7:32AM CDT
PNI Digital Media (TSX: PN)(OTCQB: PNDMF) ("PNI" or the "Company"
PNI Digital Media Announces Results of Annual General Meeting
Marketwire - Fri Mar 28, 10:54AM CDT
PNI Digital Media (TSX: PN)(OTCQX: PNDMF), ("PNI" or the "Company"
Green Plains Announces Redemption of 5.75% Convertible Senior Notes Due 2015
GlobeNewswire - Fri Feb 14, 8:00AM CST
Green Plains Renewable Energy, Inc. (Nasdaq:GPRE) announced today that it has given notice of its intention to redeem all of the outstanding 5.75% Senior Convertible Notes due 2015 (CUSIP 393222AB0) (the "2015 Convertible Notes"
Global Alzheimer's Disease Therapeutics Market to 2019: Early Stage Innovation Points to Disease Modifying Therapies and Market Transformation
M2 - Fri Feb 14, 7:56AM CST
Research and Markets (http://www.researchandmarkets.com/research/mrsfr5/alzheimers) has announced the addition of the "Global Alzheimer's Disease Therapeutics Market to 2019: Early Stage Innovation Points to Disease Modifying Therapies and Market Transformation" report to their offering. The current development pipeline shows signs of meaningful innovation, although the vast majority of these products are currently in the early stages of development. Despite one of the highest drug attrition rates across the industry, a number of innovative and potentially disease-modifying therapeutics are likely to enter the market and translate recent insights into the etiology of AD combined with an earlier therapeutic intervention into better products, which will begin to transform the AD market towards the end of the decade. The Alzheimer's Disease (AD) market is characterized by a lack of products with strong disease-modifying properties and a number of high-profile product failures in late stages of development over recent years. In addition, recent or impending patent expiries for all of the four currently marketed products and a late-stage pipeline with limited-to-moderate prospects are expected to impede growth over the next few years. In the medium-term future, the market is expected to be characterized by substantial generic competition and overall decline. Key Topics Covered: 1. Tables & Figures 2 Introduction 3 Marketed Products 4 Pipeline for Alzheimer's Disease Therapeutics 5 Market Forecast to 2019 6 Deals and Strategic Consolidations 7 Appendix For more information visit http://www.researchandmarkets.com/research/mrsfr5/alzheimers
PNI Digital Media Reports Fiscal 2014 First Quarter Financial Results
Marketwire - Tue Feb 11, 3:01PM CST
PNI Digital Media (TSX: PN)(OTCQB: PNDMF), ("PNI" or the "Company"
PNI Digital Media Sets Fiscal 2014 First Quarter Conference Call for February 11th, 2014 at 4:30pm ET
Marketwire - Wed Feb 05, 7:31AM CST
PNI Digital Media (TSX: PN)(OTCQB: PNDMF) ("PNI" or the "Company"
PNI Digital Media Announces First Photo Print App for Google Glass
Marketwire - Thu Jan 16, 7:31AM CST
PNI Digital Media (TSX: PN)(OTCQB: PNDMF), ("PNI" or the "Company"
PNI Digital Media Reports Fiscal 2013 Financial Results
Marketwire - Tue Dec 10, 3:01PM CST
PNI Digital Media (TSX: PN)(OTCQB: PNDMF), ("PNI" or the "Company"